The Federal Office for Safety in Health Care has been informed by the ECDC (European Centre for Disease Prevention and Control) that 1 additional human WNV infection has been recorded in Germany.

Recall due to yellowish discolouration of the solution

i-SPOC registration has been mandatory since September 2, 2022 and applies to all pharmaceutical companies with a centrally- or nationally-authorised human medicinal product in the EU.

Batch recall due to possible product mix

Drug authorities around the world are reminding people of the importance of reporting suspected adverse drug reactions in a joint campaign called MedSafetyWeek.

The Federal Office for Safety in Health Care has been notified by the ECDC (European Centre for Disease Prevention and Control) that another human WNV infection has been recorded in Spain.

The Federal Office for Safety in Health Care has been notified by the ECDC (European Centre for Disease Prevention and Control) that additional human WNV infections have been recorded in Greece, Italy, and Serbia.

The Federal Office for Safety in Health Care has been informed by the ECDC (European Centre for Disease Prevention and Control) that additional human WNV infections have been recorded in Germany and Greece.

The Federal Office for Safety in Health Care has been informed by the Danish authority that it has been informed by the Danish tissue bank European Sperm Bank (DK257572) that donor 8981-PARMO is a carrier of Shwachman-Bodian-Diamond syndrome (SBDS).

The Federal Office for Safety in Health Care has been notified by the ECDC (European Centre for Disease Prevention and Control) that additional human WNV infections have been recorded in Serbia and France.